ZOTA HEALTH CARE LIMITED
Latest filings
- No deviation in use of placement proceeds through September 2026 · Compliance
- Q2FY27 revenue up 55%, EBITDA turns positive; faster store expansion planned · Investor Communications
- Q2FY27 revenue up 54.58%, EBITDA turns positive · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates a generic-medicine retail pharmacy chain primarily under the Davaindia brand, with 2,579 stores across 23 states at end of FY26, after adding 997 new stores during the year (804 COCO + 193 FOFO). Davaindia contributed 77% of consolidated revenue in FY26. The chain runs two store formats: Company Owned Company Operated (COCO) and Franchise Owned Franchise Operated (FOFO). COCO gross margins exceed 70% and overall gross margin reached 60.28% in FY26. The network expanded further to 2,825 stores by end of Q1FY27 (1,855 COCO + 970 FOFO). Same-store growth has been 35-40% for stores aged 24+ months and 55-60% for stores aged 12-24 months. Through subsidiaries, additional retail pharmacy formats are being developed: Ugo Generic (KMHP Ventures, targeting B2B and B2C models) and SKIA (Curexis Ventures). Management has guided to 500-700 new Davaindia stores in FY27, with a long-term target of 5,000+ stores by FY29. Employee cost is the largest expense at 33.1% of revenue.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from ZOTA HEALTH CARE LIMITED's filed financials and exchange disclosures
What does ZOTA HEALTH CARE LIMITED do?
ZOTA HEALTH CARE LIMITED is a Pharmaceuticals & Biotechnology company listed on NSE, trading under the symbol ZOTA.
Is ZOTA HEALTH CARE LIMITED profitable?
No. Over the trailing twelve months ZOTA HEALTH CARE LIMITED reported a net loss of ₹104 Cr on revenue of ₹609 Cr.
Does ZOTA HEALTH CARE LIMITED pay a dividend?
Yes. The dividend yield is 0.07% at the current price.
Is ZOTA HEALTH CARE LIMITED debt-free?
No. It reported borrowings of ₹29 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹21 Cr after cash. Debt stands at 0.04× equity. That is lower than 63% of its 166 Pharmaceuticals peers.
How much does the ZOTA HEALTH CARE LIMITED share price move in a day?
On a typical session ZOTA HEALTH CARE LIMITED moves 1.47% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track ZOTA HEALTH CARE LIMITED's announcements?
Every NSE and BSE filing by ZOTA HEALTH CARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.